Topics

Biopharma Stock News: Immuron's (ASX: IMC) (NASDAQ: $IMRN) Technology Platform of Treatments in the Age of the #Coronavirus Outbreak

10:30 EST 3 Feb 2020 | InvestorIdeas

MELBOURNE, Australia - February 3, 2020 (Investorideas.com Newswire) Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunotherapeutics for the treatment of gut mediated diseases, announced that its commercially available

Original Article: Biopharma Stock News: Immuron's (ASX: IMC) (NASDAQ: $IMRN) Technology Platform of Treatments in the Age of the #Coronavirus Outbreak

NEXT ARTICLE

More From BioPortfolio on "Biopharma Stock News: Immuron's (ASX: IMC) (NASDAQ: $IMRN) Technology Platform of Treatments in the Age of the #Coronavirus Outbreak"

Quick Search

Relevant Topic

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...